Phibro Animal Health (PAHC) EV to CFO (2014 - 2026)
Phibro Animal Health (PAHC) posted EV to CFO of 49.44 for Q2 2026, down 63.0% on a QoQ basis from 133.62 in Q1 2026, and up 9.81% year-over-year from 45.02 in Q2 2025.
Analysis
Phibro Animal Health (PAHC) EV to CFO (2014 - 2026) Analysis & Trends
Phibro Animal Health has reported EV to CFO for 13 years, with the latest figure at 49.44 in Q2 2026.
- On a quarterly basis, EV to CFO rose 9.81% year-over-year to 49.44 in Q2 2026; TTM through Jun 2026 was 17.27, a 44.52% increase from a year earlier, with the FY2026 full-year figure at 17.27, up 44.52% from the prior year.
- EV to CFO was 49.44 for Q2 2026 at Phibro Animal Health, down from 133.62 in the prior quarter.
- The five-year high for EV to CFO was 434.3 in Q2 2022, with the low at 186.72 in Q4 2022.
- Average EV to CFO over 5 years is 74.19, with a median of 47.23 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: EV to CFO tumbled 613.55% in 2022, then jumped 2034.78% in 2024.
- Over 5 years, EV to CFO stood at 186.72 in 2022, then soared by 106.39% to 11.93 in 2023, then jumped by 2034.78% to 254.72 in 2024, then tumbled by 70.79% to 74.4 in 2025, then tumbled by 33.55% to 49.44 in 2026.
- The last three EV to CFO figures came in at 49.44 (Q2 2026), 133.62 (Q1 2026), and 74.4 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.44 |
| Mar 31, 2026 | 133.62 |
| Dec 31, 2025 | 74.40 |
| Sep 30, 2025 | 167.14 |
| Jun 30, 2025 | 45.02 |
| Mar 31, 2025 | 18.43 |
| Dec 31, 2024 | 254.72 |
| Sep 30, 2024 | 65.15 |
| Jun 30, 2024 | 19.86 |
| Mar 31, 2024 | 37.25 |
| Dec 31, 2023 | 11.93 |
| Sep 30, 2023 | 26.30 |
| Jun 30, 2023 | 23.40 |
| Mar 31, 2023 | 86.80 |
| Dec 31, 2022 | -186.72 |
| Sep 30, 2022 | -42.25 |
| Jun 30, 2022 | 434.30 |
| Mar 31, 2022 | 116.63 |
| Dec 31, 2021 | 36.36 |
| Sep 30, 2021 | 202.90 |